Peter Lynch fit · Growth at a reasonable price (GARP)
Is Caris Life Sciences, Inc. Common Stock (CAI) a Peter Lynch Stock?
Some GARP characteristics, but growth or valuation is stretched.
63/100
CMixed signals
3/6 criteria passed
Peter Lynch's Criteria, Applied to CAI
PEG ≤ 1.0
key—
EPS CAGR ≥ 15%
key26.0%
Revenue CAGR ≥ 10%
93.9%
Net margin > 0
-28.9%
How CAI Scores on Other Strategies
Live Financial Snapshot
Market cap
$7.05B
P/E (TTM)
-
ROIC (TTM)
-
Gross margin
61.3%
Frequently Asked Questions
What is CAI's Peter Lynch fit score?
CAI scores 63/100 on our Peter Lynch fit engine — grade C. Some GARP characteristics, but growth or valuation is stretched.
Does Peter Lynch actually own CAI?
Our score is computed from financial fundamentals against Peter Lynch's published criteria. We don't claim that Peter Lynch personally owns or recommends CAI.
How often is this score updated?
CAI's Peter Lynch fit score is recomputed daily from the latest TTM financials.
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Peter Lynch personally owns or recommends CAI.